BridgeMD
New treatment option for Negative Symptoms in Schizophrenia
Official title Metacognitive Training for Negative Symptoms
ClinicalTrials.gov ID: NCT06127004
What this study is testing
- What it's testing
- There is a clear rationale for developing interventions targeting negative symptoms of schizophrenia as these are a stronger indicator of current and future functioning than positive symptoms and because they respond poorly to medication and existing psychological interventions. This is reflected in the NIMH-MATRICS consensus statement that emphasised that persistent negative symptoms represent an unmet therapeutic need for patients suffering from schizophrenia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Over the age of 18
- Clinical diagnosis of schizophrenia, delusional disorder or non-affective psychosis
- Resident in Region Sörmland, Region Västmanland or Region Uppland
You likely can't join if
- Evidence of severe organic brain dysfunction
- Learning disabilities
- Difficulty with the Swedish language
- Visual and/or hearing impairment
- Being unable or unwilling to provide written informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Multiple Locations, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Multiple Locations, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.